F082 The Metabolic Revolution: Training Dermatologists to be Prepared for/Incorporate/Utilize GLP-1 Agonists and Other Antidiabetics in Skin Disease
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Given the overwhelming evidence that adiposity and insulin resistance lead to an inflammatory state, addressing inflammatory diseases in dermatology without an understanding or plan to address metabolic dysfunction ultimately leads to incomplete response to treatment, unnecessary escalation of anti-inflammatory and immunosuppressive medications, and poor outcomes. We will discuss how metabolic dysfunction is recognized on physical examination, analyzed through bloodwork, and can be treated by dermatologists as part of a comprehensive therapy plan. Further, dermatologists are often the only opportunity for recognition and diagnosis of metabolic dysfunction so additional referral recommendations and nutrition/lifestyle counseling will be discussed.
LEARNING OBJECTIVES
Demonstrate to role of adiposity and insulin resistance in inflammatory conditions including acne, hidradenitis suppurativa, psoriasis, cicatricial alopecia, atopic dermatitis, and urticaria.
Identify metabolic dysfunction clinically and by analysis of bloodwork to determine if this needs to be addressed as part of a holistic approach to their inflammatory condition.
Discuss treatment options and lifestyle modifications that dermatologists can use with standard therapies to improve patient outcome in the inflammatory conditions discussed.
SCHEDULE
1:00 PM
Overview of metabolic disorder and affect on inflammation
Lindsey Bordone, MD, FAAD
1:30 PM
Update on metabolic therapies for hair loss conditions
Crystal Aguh, MD, FAAD
1:50 PM
Hidradenitis suppurativa and insulin
Ginette Okoye, MD, FAAD
2:10 PM
Nutritional chemistry and dietary recommendations for patients
Katy Burris, MD, FAAD
2:30 PM
Selective insulin resistance, how to spot, and basics for treatment
Joshua Cook, MD, PhD
SPEAKERS
Crystal Aguh, MD, FAAD
Lindsey Bordone, MD, FAAD
Katy Burris, MD, FAAD
Joshua Cook, MD, PhD
Ginette Okoye, MD, FAAD
HANDOUTS
SPEAKER DISCLOSURES
Crystal Aguh, MD, FAAD
CP Skin Health – Advisory Board(Honoraria); Eli Lilly and Company – Consultant(Fees); janssen – Other(Residency/Fellowship Program Funding); Myovant Sciences – Advisory Board(Fees); Olaplex – Advisory Board(Fees); Pfizer Inc. – Consultant(Fees); Procter & Gamble Company – Consultant (1099 relationship)(Fees); UpToDate, Inc – Other(Fees);
Lindsey Bordone, MD, FAAD
No financial relationships exist with ineligible companies.
Katy Burris, MD, FAAD
Bristol Myers Squibb – Advisory Board(Honoraria); EBSCO Industries, Inc. – Independent Contractor(Fees);
Joshua Cook, MD, PhD
No financial relationships exist with ineligible companies.
Ginette Okoye, MD, FAAD
AbbVie – Advisory Board(Honoraria); Dermatology Foundation – Board of Directors(No Compensation Received); Hidradenitis Suppurativa Foundation – Board of Directors(No Compensation Received); Incyte Corporation – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria), Investigator(Residency/Fellowship Program Funding); L'Oreal – Consultant (1099 relationship)(Honoraria); Mercado Innovations, Inc – Consultant (1099 relationship)(Stock Options); Novartis – Advisory Board(Honoraria); Nutrafol – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Residency/Fellowship Program Funding); Sandoz, a Novartis company – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria); Unilever – Consultant(Honoraria); Vaseline Healing Project – Advisory Board(Honoraria);